Want to join the conversation?
$ZBH said that it accelerated its US Knee performance in 1Q16, which contributed to a 3.3% YoverY sales increase in the Americas. The company maintained strong revenues in the Asia-Pacific region, delivering growth of 7.2%. $ZBH said that its knee sales rose by 1.9% in EMEA region vs. 1Q15. Knee results were driven by Persona.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?